Literature DB >> 3126352

Analbuminaemia: a natural model of metabolic compensatory systems.

G Baldo-Enzi1, M R Baiocchi, G Vigna, C Andrian, C Mosconi, R Fellin.   

Abstract

Important clinical signs are usually not present in analbuminaemia, a congenital condition inherited as an autosomal recessive trait, but several biochemical alterations in proteins, cholesterol, phospholipids and plasma beta lipoproteins have been observed. We studied two sibs, R.U. and R.R., with this disease and observed a striking increase in the variables mentioned above as well as a high LDL fraction with concomitant increase in apo B; increases in HDL3 and apo A-I and A-II levels were also observed. The lipoproteins, however, were not altered in morphology but showed a slight increase in lipid/protein ratio. Post-heparin lipolytic activity was normal in the male patient and reduced in the female while LCAT enzyme activity instead was increased in both. Fatty acids bound to phospholipids and serum cholesterol were mostly monounsaturated. Free fatty acid concentration was normal and they appeared mostly bound to the LDL and HDL3 fractions, which are increased in this disease and appear to replace albumin in one of its main carrier functions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3126352     DOI: 10.1007/bf01799973

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  30 in total

1.  [Biochemical study on the 1st case of analbuminemia in France].

Authors:  J P Goulé; G Laine; F Sauger; B Maitrot; A Bouillerot; H Gray; P Blondet; B Dieryck
Journal:  Ann Biol Clin (Paris)       Date:  1976       Impact factor: 0.459

2.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

3.  [Analbuminemia].

Authors:  H Keller; G Noseda; A Morell; G Riva
Journal:  Minerva Med       Date:  1972-03-24       Impact factor: 4.806

Review 4.  Fatty acid binding to plasma albumin.

Authors:  A A Spector
Journal:  J Lipid Res       Date:  1975-05       Impact factor: 5.922

5.  Post-heparin plasma lipoprotein lipase and hepatic lipase in normal subjects and in patients with hypertriglyceridaemia: correlations to sex, age and various parameters of triglyceride metabolism.

Authors:  J K Huttunen; C Ehnholm; M Kekki; E A Nikkilä
Journal:  Clin Sci Mol Med       Date:  1976-04

6.  Analbuminemia in an American Indian girl.

Authors:  H Boman; M Hermodson; C A Hammond; A G Motulsky
Journal:  Clin Genet       Date:  1976-05       Impact factor: 4.438

7.  Analbuminemia in a neonate.

Authors:  E J Cormode; D M Lyster; S Israels
Journal:  J Pediatr       Date:  1975-06       Impact factor: 4.406

8.  A seven-base-pair deletion in an intron of the albumin gene of analbuminemic rats.

Authors:  H Esumi; Y Takahashi; S Sato; S Nagase; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

9.  Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure.

Authors:  L I Gidez; G J Miller; M Burstein; S Slagle; H A Eder
Journal:  J Lipid Res       Date:  1982-11       Impact factor: 5.922

10.  Morphologic, biochemical and physiologic alterations in a case of idiopathic hypoalbuminemia (analbuminemia).

Authors:  J V Weinstock; H Kawanishi; J Sisson
Journal:  Am J Med       Date:  1979-07       Impact factor: 4.965

View more
  8 in total

1.  A nucleotide insertion and frameshift cause analbuminemia in an Italian family.

Authors:  S Watkins; J Madison; M Galliano; L Minchiotti; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

2.  Clinical chemistry of human FcRn transgenic mice.

Authors:  Carsten Stein; Lothar Kling; Gabriele Proetzel; Derry C Roopenian; Martin Hrabě de Angelis; Eckhard Wolf; Birgit Rathkolb
Journal:  Mamm Genome       Date:  2011-12-23       Impact factor: 2.957

3.  Analbuminemia: three cases resulting from different point mutations in the albumin gene.

Authors:  S Watkins; J Madison; M Galliano; L Minchiotti; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

4.  Trans-splicing into highly abundant albumin transcripts for production of therapeutic proteins in vivo.

Authors:  Jun Wang; S Gary Mansfield; Colette A Cote; Ping Du Jiang; Ke Weng; Marcelo J A Amar; Bryan H Brewer; Alan T Remaley; Gerard J McGarrity; Mariano A Garcia-Blanco; M Puttaraju
Journal:  Mol Ther       Date:  2008-12-09       Impact factor: 11.454

5.  Treatment of a patient with congenital analbuminemia with atorvastatin and albumin infusion.

Authors:  Maria Del Ben; Francesco Angelico; Lorenzo Loffredo; Francesco Violi
Journal:  World J Clin Cases       Date:  2013-04-16       Impact factor: 1.337

6.  Lack of plasma albumin impairs intravascular lipolysis and explains the associated free fatty acids deficiency and hypertriglyceridemia.

Authors:  Tiago R Figueira; Aníbal E Vercesi; Helena C F Oliveira
Journal:  Lipids Health Dis       Date:  2010-12-27       Impact factor: 3.876

7.  Albumin-deficient mouse models for studying metabolism of human albumin and pharmacokinetics of albumin-based drugs.

Authors:  Derry C Roopenian; Benjamin E Low; Gregory J Christianson; Gabriele Proetzel; Thomas J Sproule; Michael V Wiles
Journal:  MAbs       Date:  2015       Impact factor: 5.857

8.  Congenital analbuminemia in a patient affected by hypercholesterolemia: A case report.

Authors:  Patrizia Suppressa; Concetta Carbonara; Francesca Lugani; Monica Campagnoli; Teresa Troiano; Lorenzo Minchiotti; Carlo Sabbà
Journal:  World J Clin Cases       Date:  2019-02-26       Impact factor: 1.337

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.